KYORIN Holdings, Inc. [4569.T]

Last updated: 27 jan 2023 @ 01:15
Share On:

-0.18% JPY1 708.00

Sell
Profile picture for KYORIN Holdings, Inc.

KYORIN Holdings, Inc., through its subsidiaries, researches and develops, produces, and sells ethical and generic drugs in Japan and internationally. The company offers Flutiform, a drug for the treatment of asthma; Desalex, an antiallergic agent; Beova, Uritos, and Imidafenacin KYORIN therapeutic agents for overactive bladder; Lasvic, a quinolone synthetic antibacterial agent; Pentasa, a remedy for ulcerative colitis/Crohn's disease; Nasonex, an allergic rhinitis therapeutic agent; and Kipres, a leukotriene receptor antagonist anti-bronchial asthma and allergic rhinitis drug...

Stats
Current Price JPY1 708.00
Today's Volume 25 100T
Average Volume 69 788T
Market Cap 97.87B
EPS 88.19
P/E 19.37
ATR14 JPY0.903 (0.05%)